🔎 Trials Near Me

Home › Psychotic Disorders › NCT04368039

Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis

Recruiting

Who can join

Ages 15 to 35 · All sexes

Full eligibility criteria
* Diagnosis of a schizophrenia-spectrum disorder or mood disorder with psychotic features as determined using the Structured Clinical Interview for the DSM-5.
* Less than 5 years since the onset of frank psychotic symptoms as determined using the Symptom Onset in Schizophrenia Inventory .
* No evidence of a pre-existing intellectual disability defined as a premorbid IQ \>70 as estimated using the Reading subtest of the Wide Range Achievement Test-4.
* Ages 15-35
* Non-smoker for past six months
* Absence of suicidal ideation or behavior over the past month as assessed by the Columbia Suicide Severity Rating Scale
* The American Association for Respiratory Care notes that "no absolute contraindications to oxygen therapy exist when indications \[for oxygen therapy\] are present."

About the study

Single-blind, randomized controlled trial of normobaric oxygen therapy among individuals with first-episode psychosis: Effects on symptomatology and cognition.

What is being tested

Sponsor: Nicholas Breitborde · Participants: 20 · Started: Dec 4, 2019

Contact the study team

Official record on ClinicalTrials.gov — NCT04368039

Locations in the U.S.

OhioHarding Hospital, Columbus

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.